06/09/2025
9:03 AM | Gopinathan Suma (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
4:40 PM | Lexicon Pharmaceuticals (Issuer)
Martens Rachel Yap (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2025
6:08 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
4:48 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:49 PM | Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:50 PM | BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:50 PM | Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:51 PM | Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:52 PM | Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
6:11 AM | Lexicon Pharmaceuticals (Filer)
| Form ARS | |
04/22/2025
6:07 AM | Lexicon Pharmaceuticals (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for LXRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/22/2025
6:09 AM | Lexicon Pharmaceuticals (Filer)
| Form DEFA14A | |
03/28/2025
6:59 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
3:31 PM | Granowitz Craig B (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:32 PM | Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:33 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:33 PM | Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:08 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:04 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:06 PM | Coiante Scott M (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2024
6:00 PM | Artal Participations S.a r.l. (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/09/2024
8:33 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/02/2024
4:40 PM | Cheung Ivan (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/02/2024
4:41 PM | Cheung Ivan (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:05 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
6:12 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024
3:37 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
3:58 PM | DeFrancesco Lisa (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/16/2024
5:51 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
11:15 PM | Lexicon Pharmaceuticals (Filer)
| Form EFFECT | |
08/15/2024
3:47 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
7:39 AM | Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
7:40 AM | Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
8:37 AM | Lexicon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/02/2024
6:06 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
4:44 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
07/29/2024
4:31 PM | Invus Global Management, LLC (Reporting)
Lexicon Pharmaceuticals (Issuer)
Siren, L.L.C. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
9:10 AM | FMR LLC (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G | |
07/08/2024
4:26 PM | Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/08/2024
4:27 PM | Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
How high will gold surge? (Ad)
Weiss Gold Veteran Makes Shocking New Call
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold … and reveals a little-known way to get ahead of this bull market. Watch this time-sensitive gold bulletin now. |
07/08/2024
4:27 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
8:15 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy LXRX Stock Free LXRX Stock Alerts